Multiple Myeloma Therapeutics Market to reach USD 10 billion by 2023
The Global Multiple Myeloma Therapeutics Market was worth USD 7.91 billion in 2018 and estimated to be growing at a CAGR of 4.8%, to reach USD 10 billion by 2023
(EMAILWIRE.COM, July 25, 2018 ) Multiple myeloma majorly affects kidney, bone and blood. Patients suffering from multiple myeloma generally show several symptoms such as fatigue, loss of appetite, bone pain and increased urination.
The Global Multiple Myeloma Therapeutics Market was worth USD 7.91 billion in 2018 and estimated to be growing at a CAGR of 4.8%, to reach USD 10 billion by 2023.
Key Points from TOC
5.1 By Treatment Type
5.1.1 Chemotherapy
5.1.1.1 Anthracycline antibiotic
5.1.1.2 Alkylating agent
5.1.2 Targeted Therapy
5.1.2.1 Proteasome inhibitor
Request sample report at https://www.marketdataforecast.com/market-reports/global-multiple-myeloma-therapeutics-market-858/request-sample
5.2 By Drug Type
5.2.1 Corticosteroids
5.2.1.1 Dexamethasone (Decadron)
5.2.1.2 Prednisone (Deltasone/Orasone)
5.2.2 Immunomodulatory agents
5.2.2.1 Thalidomide (Thalomid)
5.2.2.2 Lenalidomide (Revlimid)
5.2.2.3 Arsenic trioxide (Trisenox)
5.2.2.4 Plerixafor (Mozobil)
Read more Insights at https://www.marketdataforecast.com/market-reports/global-multiple-myeloma-therapeutics-market-858/
Geographically Multiple Myeloma Therapeutics Market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
Multiple Myeloma Therapeutics Market Key Players include AB Science SA, AbbVie Inc., Ablynx NV, Acceleron Pharma Inc., IGF Oncology LLC. , ImmunGene Inc., Millennium Pharmaceuticals Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Terpenoid Therapeutics Inc. ,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and Johnson and Johnson.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
The Global Multiple Myeloma Therapeutics Market was worth USD 7.91 billion in 2018 and estimated to be growing at a CAGR of 4.8%, to reach USD 10 billion by 2023.
Key Points from TOC
5.1 By Treatment Type
5.1.1 Chemotherapy
5.1.1.1 Anthracycline antibiotic
5.1.1.2 Alkylating agent
5.1.2 Targeted Therapy
5.1.2.1 Proteasome inhibitor
Request sample report at https://www.marketdataforecast.com/market-reports/global-multiple-myeloma-therapeutics-market-858/request-sample
5.2 By Drug Type
5.2.1 Corticosteroids
5.2.1.1 Dexamethasone (Decadron)
5.2.1.2 Prednisone (Deltasone/Orasone)
5.2.2 Immunomodulatory agents
5.2.2.1 Thalidomide (Thalomid)
5.2.2.2 Lenalidomide (Revlimid)
5.2.2.3 Arsenic trioxide (Trisenox)
5.2.2.4 Plerixafor (Mozobil)
Read more Insights at https://www.marketdataforecast.com/market-reports/global-multiple-myeloma-therapeutics-market-858/
Geographically Multiple Myeloma Therapeutics Market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
Multiple Myeloma Therapeutics Market Key Players include AB Science SA, AbbVie Inc., Ablynx NV, Acceleron Pharma Inc., IGF Oncology LLC. , ImmunGene Inc., Millennium Pharmaceuticals Inc., MimiVax LLC, Mirna Therapeutics, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Terpenoid Therapeutics Inc. ,Teva Pharmaceutical Industries Ltd. ,TG Therapeutics Inc. and Johnson and Johnson.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results